Vinod Jaskula-Ranga

Vinod Jaskula-Ranga is the founder, president, and CEO of Hunterian Medicine, a pre-clinical biotech company focused on CRISPR gene-editing technologies. He is the lead inventor on over 75 pending US and international patents, including a CRISPR and AAV therapeutic-delivery technology. Jaskula-Ranga’s research has been highlighted by Chemical & Engineering News, Genetic Engineering & Biotechnology News, Biotechniques, Xconomy, and GenomeWeb, among others. Prior to starting Hunterian Medicine, he completed a fellowship in genetic engineering and molecular ophthalmology at the Wilmer Eye Institute of the Johns Hopkins University School of Medicine, where he received his doctorate in molecular biology and genetics and trained in the laboratory of Nobel Prize laureate Carol Greider.